Hilltop BioSciences
- Company typePrivate
- Founded2018
- HeadquartersMansfield, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Hilltop BioSciences firmographics
Firmographics- Name
- Hilltop BioSciences
- Legal name
- Hilltop BioSciences, Inc.
- Website
- https://hilltopbio.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Hilltop BioSciences industry classification
Industry- Product category
- Veterinary Regenerative Biologics
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Veterinary Services (541940)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Equine Therapeutics (Rx) (HLAMAEAC)
- akta.pro secondary industries
- Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing) (HLAMANAI), Exosome & Extracellular Vesicle (EV) Therapeutics (HLAMANAE)
Keywords
Where Hilltop BioSciences is headquartered
LocationHeadquarters
- HQ city
- Mansfield
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hilltop BioSciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel
Revenue model
- Veterinary Biologic Product Sales: Hilltop Bio generates revenue through the sale of regenerative biologic products to licensed veterinarians. Products include Regenaflex-RT, Regenaflex-K9, Strydaflex, Strydaflex-K9, Regenaflex-M, Regenaflex-Gel, PureOptic, and Regenaflex-M 25mm discs. Sales occur through a B2B e-commerce platform requiring veterinary registration and through veterinary distribution partners. Products are priced up to $1,300 per unit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Unit-based product pricing for veterinary regenerative biologics across four therapeutic categories: soft tissue, joint health, wound care, and ophthalmic health. |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels8 records
Hilltop BioSciences product offering
Product offeringCore offering
Hilltop Bio develops and manufactures a portfolio of regenerative biologic products derived from equine birth-derived tissues using its proprietary BioStabyl™ lyophilization process. The products are sold exclusively to licensed veterinarians for the treatment of soft tissue injuries, joint conditions, wound care, and ophthalmic conditions in equine and canine patients. The portfolio spans Regenaflex, Strydaflex, and PureOptic product lines.
Product overview
Hilltop Bio is a veterinary biotechnology company offering a portfolio of seven commercially available regenerative biologic products for equine and canine patients, plus one product in development. The product line spans four therapeutic categories: SOFT TISSUE (Regenaflex-RT and Regenaflex-K9 containing bioscaffold materials), JOINT HEALTH (Strydaflex and Strydaflex-K9 with proteomically characterized factors), WOUND CARE (Regenaflex-M membrane and Regenaflex-Gel topical), and OPHTHALMIC HEALTH (PureOptic). All products are derived from birth-derived tissue using the proprietary BioStabyl™ lyophilization process, are room-temperature stable, and require veterinary authorization. The company also has LPAT in development, an amnion-derived therapy for feline applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Regenaflex-RT Lyophilized bioscaffold material sourced from birth-derived tissue that supports the ingrowth of reparative tissues for management of soft tissue injuries in equine patients; sold exclusively to licensed veterinarians.
- Regenaflex-K9 Lyophilized bioscaffold material sourced from birth-derived tissue designed for canine soft tissue applications to support the ingrowth of reparative tissues; sold exclusively to licensed veterinarians.
- Strydaflex Lyophilized intra-articular joint health product for equine patients with proteomic characterization showing consistent levels of factors that play a beneficial role in the body's normal response to joint damage; sold exclusively to licensed veterinarians.
- Strydaflex-K9 Lyophilized intra-articular joint health product for canine patients with proteomic characterization showing consistent levels of factors that support the body's normal response to joint damage; sold exclusively to licensed veterinarians.
- Regenaflex-M Sterile lyophilized bioscaffold membrane for wound care applications designed to protect and supplement tissue integration; available in 8 x 10cm, 6 x 6cm, and 25mm disc sizes; sold exclusively to licensed veterinarians.
- Regenaflex-Gel Lyophilized topical gel bioscaffold for superficial wound care and summer sores where membrane application is not feasible, providing bioscaffold support for tissue healing; sold exclusively to licensed veterinarians.
- PureOptic Lyophilized ophthalmic biologic with optimized viscosity formulation designed to ensure the solution maintains longer-lasting contact with affected ocular tissue (e.g., corneal ulcers); sold exclusively to licensed veterinarians.
Quantifiable outcome
- Trusted in over 1,000 clinics by general practitioners and board-certified specialists
- +3 more outcomes
Companies that use Hilltop BioSciences
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Hilltop BioSciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Hilltop BioSciences partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- Midwest Veterinary SupplycoreHilltop Bio announced a strategic distribution partnership with Midwest Veterinary Supply in November 2025. The partnership is designed to strengthen and expand access to Hilltop Bio's regenerative therapy products for equine and canine health across the United States veterinary market.
- CovetruscoreCovetrus is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Covetrus is a major U.S. veterinary distribution company serving practices nationwide.
- MWI (AmerisourceBergen Animal Health)coreMWI is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. MWI is a major U.S. veterinary supply distributor.
- Patterson VeterinarycorePatterson Veterinary is featured as part of Hilltop Bio's 'Proudly Distributed By' distribution network. Patterson Veterinary is a major U.S. veterinary supply distributor.
- Not One More Vet (NOMV)minorHilltop Bio partners with NOMV, a U.S.-based nonprofit supporting veterinary mental health. The company donates $1 for every unit of product sold to support NOMV's mental health programs. Contributions have exceeded $15,000 over the past two years. The partnership also includes matching donations during AAEP Conference.
- EQUUS FoundationminorHilltop Bio is a corporate partner of the EQUUS Foundation, the only national U.S. animal welfare organization dedicated to protecting horses. Hilltop Bio has established a $2,500 veterinary scholarship for students at Texas Tech University Veterinary School and donates up to $5,000 in products for the Foundation's Guardian charities through the Lafitte De Muze Matching Gift Campaign.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Hilltop BioSciences competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Hilltop BioSciences social profiles
Digital presenceHilltop BioSciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hilltop BioSciences leadership team
Management profileNumber of profiles
Profiles8 records
Hilltop BioSciences funding detail
Funding detailFunding overview
Funding rounds5 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hilltop BioSciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hilltop BioSciences
What does Hilltop BioSciences do?
Hilltop Bio develops and manufactures a portfolio of regenerative biologic products derived from equine birth-derived tissues using its proprietary BioStabyl™ lyophilization process. The products are sold exclusively to licensed veterinarians for the treatment of soft tissue injuries, joint conditions, wound care, and ophthalmic conditions in equine and canine patients. The portfolio spans Regenaflex, Strydaflex, and PureOptic product lines.
Is Hilltop BioSciences a public or private company?
Hilltop BioSciences is a private company. It is classified as venture growth investor backed and is currently operating.
When was Hilltop BioSciences founded?
Hilltop BioSciences was founded in 2018. It employs 1 to 10 people.
Where is Hilltop BioSciences based?
Hilltop BioSciences is headquartered in Mansfield, United States, in the North America region.
How does Hilltop BioSciences make money?
One revenue line is on record: veterinary Biologic Product Sales.
Does Hilltop BioSciences have an API?
No public API is recorded for Hilltop BioSciences.
What industry is Hilltop BioSciences in?
Hilltop BioSciences's product category is Veterinary Regenerative Biologics. Its primary akta.pro industry code is HLAMAEAC, Equine Therapeutics (Rx), with a secondary code of HLAMANAI, Veterinary Regenerative Medicine Manufacturing (GMP/CDMO, Cell Processing). Its NAICS code is 325414 and its SIC code is 2836.